- Home
- SRZN vs NCZ Comparison
SRZN vs NCZ Comparison
Compare SRZN & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRZN | NCZ |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | 44 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.9M | 271.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SRZN | NCZ |
|---|---|---|
| Price | $28.66 | $14.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | ★ 115.4K | 78.7K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $75.35 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.11 | $11.48 |
| 52 Week High | $33.96 | $15.04 |
Technical Indicators
Market Signals| Indicator | SRZN | NCZ |
|---|---|---|
| Relative Strength Index (RSI) | 48.49 | 63.33 |
| Support Level | $23.95 | $13.07 |
| Resistance Level | $29.18 | $14.99 |
| Average True Range (ATR) | 2.42 | 0.22 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 38.27 | 92.83 |
Price Performance
Historical ComparisonAbout SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.